Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer

Kakoli Das, David Tai Leong, Anurag Gupta, Liang Shen, Thomas Putti, Gary S. Stein, Andre J van Wijnen, Manuel Salto-Tellez

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Purpose: The runt-related transcription factor, Runx2 may have an oncogenic role in mediating metastatic events in breast cancer, but whether Runx2 has a role in the early phases of breast cancer development is not clear. We examined the expression of Runx2 and its relationship with oestrogen receptor (ER) and progesterone receptor (PR) in breast cancer cell lines and tissues. Methods: Two human breast cancer cell lines, MCF-7 and MDA-MB-231 were transiently transfected with vectors expressing either Runx2 or ER and the levels of both proteins and mRNA were examined by Western blot analysis and quantitative real-time PCR, respectively. Runx2 expression was also examined in tissue microarray sections of 123 breast cancer patients by immunohistochemistry and results were correlated with clinico-pathological characteristics. Results: Expression of Runx2 and ER was reciprocal in the breast cell culture models and Runx2 suppressed ERβ but not ERα mRNA levels. In contrast, functional expression of Runx2 was evident in the nucleus in 28% of the breast cancer tissues and in both early and late stages of tumour growth. Importantly, Runx2 expression was significantly more frequent in Grade 2 compared to Grade 1 and Grade 3 tumours (48% versus 39% versus 13%) and the expression was significantly associated with ER (p = 0.005), PR (p = 0.008) expressions in Grade 2 & Grade 3 tumours than Grade 1 tumours. Conclusion: We propose that Runx2, ER and PR triple positivity in Grades 2 and 3 defines a biological subtype in breast cancer.

Original languageEnglish (US)
Pages (from-to)2239-2248
Number of pages10
JournalEuropean Journal of Cancer
Volume45
Issue number13
DOIs
StatePublished - Sep 2009
Externally publishedYes

Fingerprint

Progesterone Receptors
Estrogen Receptors
Breast Neoplasms
Gene Expression
Neoplasms
Cell Line
Messenger RNA
Real-Time Polymerase Chain Reaction
Breast
Transcription Factors
Cell Culture Techniques
Western Blotting
Immunohistochemistry
Growth
Proteins

Keywords

  • Breast cancer
  • CerbB2
  • Oestrogen receptor
  • Progesterone receptor
  • Runx2

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer. / Das, Kakoli; Leong, David Tai; Gupta, Anurag; Shen, Liang; Putti, Thomas; Stein, Gary S.; van Wijnen, Andre J; Salto-Tellez, Manuel.

In: European Journal of Cancer, Vol. 45, No. 13, 09.2009, p. 2239-2248.

Research output: Contribution to journalArticle

Das, Kakoli ; Leong, David Tai ; Gupta, Anurag ; Shen, Liang ; Putti, Thomas ; Stein, Gary S. ; van Wijnen, Andre J ; Salto-Tellez, Manuel. / Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer. In: European Journal of Cancer. 2009 ; Vol. 45, No. 13. pp. 2239-2248.
@article{95b0b4a09d874e1bbd714f426b9565b5,
title = "Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer",
abstract = "Purpose: The runt-related transcription factor, Runx2 may have an oncogenic role in mediating metastatic events in breast cancer, but whether Runx2 has a role in the early phases of breast cancer development is not clear. We examined the expression of Runx2 and its relationship with oestrogen receptor (ER) and progesterone receptor (PR) in breast cancer cell lines and tissues. Methods: Two human breast cancer cell lines, MCF-7 and MDA-MB-231 were transiently transfected with vectors expressing either Runx2 or ER and the levels of both proteins and mRNA were examined by Western blot analysis and quantitative real-time PCR, respectively. Runx2 expression was also examined in tissue microarray sections of 123 breast cancer patients by immunohistochemistry and results were correlated with clinico-pathological characteristics. Results: Expression of Runx2 and ER was reciprocal in the breast cell culture models and Runx2 suppressed ERβ but not ERα mRNA levels. In contrast, functional expression of Runx2 was evident in the nucleus in 28{\%} of the breast cancer tissues and in both early and late stages of tumour growth. Importantly, Runx2 expression was significantly more frequent in Grade 2 compared to Grade 1 and Grade 3 tumours (48{\%} versus 39{\%} versus 13{\%}) and the expression was significantly associated with ER (p = 0.005), PR (p = 0.008) expressions in Grade 2 & Grade 3 tumours than Grade 1 tumours. Conclusion: We propose that Runx2, ER and PR triple positivity in Grades 2 and 3 defines a biological subtype in breast cancer.",
keywords = "Breast cancer, CerbB2, Oestrogen receptor, Progesterone receptor, Runx2",
author = "Kakoli Das and Leong, {David Tai} and Anurag Gupta and Liang Shen and Thomas Putti and Stein, {Gary S.} and {van Wijnen}, {Andre J} and Manuel Salto-Tellez",
year = "2009",
month = "9",
doi = "10.1016/j.ejca.2009.06.021",
language = "English (US)",
volume = "45",
pages = "2239--2248",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "13",

}

TY - JOUR

T1 - Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer

AU - Das, Kakoli

AU - Leong, David Tai

AU - Gupta, Anurag

AU - Shen, Liang

AU - Putti, Thomas

AU - Stein, Gary S.

AU - van Wijnen, Andre J

AU - Salto-Tellez, Manuel

PY - 2009/9

Y1 - 2009/9

N2 - Purpose: The runt-related transcription factor, Runx2 may have an oncogenic role in mediating metastatic events in breast cancer, but whether Runx2 has a role in the early phases of breast cancer development is not clear. We examined the expression of Runx2 and its relationship with oestrogen receptor (ER) and progesterone receptor (PR) in breast cancer cell lines and tissues. Methods: Two human breast cancer cell lines, MCF-7 and MDA-MB-231 were transiently transfected with vectors expressing either Runx2 or ER and the levels of both proteins and mRNA were examined by Western blot analysis and quantitative real-time PCR, respectively. Runx2 expression was also examined in tissue microarray sections of 123 breast cancer patients by immunohistochemistry and results were correlated with clinico-pathological characteristics. Results: Expression of Runx2 and ER was reciprocal in the breast cell culture models and Runx2 suppressed ERβ but not ERα mRNA levels. In contrast, functional expression of Runx2 was evident in the nucleus in 28% of the breast cancer tissues and in both early and late stages of tumour growth. Importantly, Runx2 expression was significantly more frequent in Grade 2 compared to Grade 1 and Grade 3 tumours (48% versus 39% versus 13%) and the expression was significantly associated with ER (p = 0.005), PR (p = 0.008) expressions in Grade 2 & Grade 3 tumours than Grade 1 tumours. Conclusion: We propose that Runx2, ER and PR triple positivity in Grades 2 and 3 defines a biological subtype in breast cancer.

AB - Purpose: The runt-related transcription factor, Runx2 may have an oncogenic role in mediating metastatic events in breast cancer, but whether Runx2 has a role in the early phases of breast cancer development is not clear. We examined the expression of Runx2 and its relationship with oestrogen receptor (ER) and progesterone receptor (PR) in breast cancer cell lines and tissues. Methods: Two human breast cancer cell lines, MCF-7 and MDA-MB-231 were transiently transfected with vectors expressing either Runx2 or ER and the levels of both proteins and mRNA were examined by Western blot analysis and quantitative real-time PCR, respectively. Runx2 expression was also examined in tissue microarray sections of 123 breast cancer patients by immunohistochemistry and results were correlated with clinico-pathological characteristics. Results: Expression of Runx2 and ER was reciprocal in the breast cell culture models and Runx2 suppressed ERβ but not ERα mRNA levels. In contrast, functional expression of Runx2 was evident in the nucleus in 28% of the breast cancer tissues and in both early and late stages of tumour growth. Importantly, Runx2 expression was significantly more frequent in Grade 2 compared to Grade 1 and Grade 3 tumours (48% versus 39% versus 13%) and the expression was significantly associated with ER (p = 0.005), PR (p = 0.008) expressions in Grade 2 & Grade 3 tumours than Grade 1 tumours. Conclusion: We propose that Runx2, ER and PR triple positivity in Grades 2 and 3 defines a biological subtype in breast cancer.

KW - Breast cancer

KW - CerbB2

KW - Oestrogen receptor

KW - Progesterone receptor

KW - Runx2

UR - http://www.scopus.com/inward/record.url?scp=68749118305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68749118305&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2009.06.021

DO - 10.1016/j.ejca.2009.06.021

M3 - Article

VL - 45

SP - 2239

EP - 2248

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 13

ER -